NeuraSeed BCI Expo 2024

🧠 Exclusive: Presenting the NeuraSeed BCI Virtual World Fair 🧠 Brain-Computer Interface (BCI) is a revolutionary technology that allows direct communication between the brain and external devices. By bypassing conventional pathways of communication, BCIs create a direct link between neural activity and digital systems, opening up new possibilities in various fields. This cutting-edge technology is at the forefront of neuroscience and bioengineering, promising to transform not only how we interact with machines but also how we understand and utilize the capabilities of the human brain. Neilank and his team at NeuraSeed BCI are bringing together industry professionals, academic researchers, and students across a wide range of disciplines to explore the field of Brain-Computer Interface (BCI). In one afternoon, the NeuraSeed BCI Expo 24 will feature presentations, panels, and exhibits from the top leaders who are advancing research, product development, and clinical translation for emerging applications of BCI technology. Who's Speaking? 🙋♂️ Neilank K. Jha, - Executive Chairman & CEO at NeuraSeed BCI Julian Bailes, M.D. - President at Subcortical Surgery Group Rob Franklin - VP BCI at Blackrock Neurotech Benjamin Rapoport - Co-Founder/CSO at Precision Neuroscience J Mocco - CMO at Synchron Vikash Gilja - CSO at Paradromics Inc. and many more! 🎉 What's the best part? It's totally free... 🎉 Sign up using the link: https://lnkd.in/gD4HvS8v #BCI #Neuroscience #Neuromodulation #NeuraseedBCI24

Great insights from our Conference Chair Dr. Neilank K. Jha, MD, FRCS(C), MSc, MBA!

On this month's issue of the NeuraSeed BCI Expo 2024 Newsletter: - Precision Neuroscience Sets Record for Most Electrodes on a Human Brain - Science Corporation Acquires Retinal Implant from Pixium Vision S.A. - FDA Announces Their Membership in the iBCI-CC Read more below... #BCI #Neurotech #Neuroscience NeuraSeed BCI

I am proud to announce Dr. Benjamin Rapoport, Co-Founder and Chief Science Officer of Precision Neuroscience, as our next speaker in our conference series. Dr. Rapoport co-founded Neuralink with Elon Musk; he not only obtained his MD from Harvard Medical School Department of Biomedical Informatics and pursued a residency in Neurosurgery, but has his Master's in Mathematics from University of Oxford and PhD in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology. Our team met with Dr. Rapoport's team several months ago and they shared our excitement in having Dr. Rapoport present his insights and groundbreaking work at the Expo. We're fortunate to have someone with his pedigree and knowledge participate at our conference.  - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair

The NeuraSeed BCI Essay Competition is now open to all Undergraduate Attendees. This is your chance to win a prestigious scholarship, and be celebrated at the conference's closing ceremony. Don't miss this opportunity to make your mark as a future founder in the BCI space!

By the Numbers Age is just a number; the average age of the NeuraSeed BCI Expo 2024 organizing team is 21.3 years old. I'm proud of our team of Amanda, Daniel, Clint, Julia, Dylan, Ahsas, Ryan, Joshua, Yalda and Sebastian where the average age is 21.3 years old and they have singlehandedly organized one of the largest Brain-Computer Interface (BCI) Conferences. Starting just 14 weeks ago, we now have representation from over 175 academic institutions, over 50 countries and over 1000 attendees. It is a privilege to lead this team, but more importantly learn from them. To me, this generation is the hardest working and most talented we have seen. What they require is purpose, opportunity and incentive. Thank you team.

It is my pleasure to announce Dr. Vikash Gilja, Chief Scientific Officer of Paradromics Inc., as our next speaker in our conference series. Dr. Gilja is a pioneer in the BCI space; he not only obtained his Master's in Electrical Engineering and Computer Science from Massachusetts Institute of Technology and PhD in Computer Science from Stanford University, but he co-founded its Neural Prosthetics Translational Laboratory (TNEL). During his time at Stanford, he became a part of the BrainGate Team and thereafter the technical team at Neuralink. I met with Dr. Gilja several months ago and he shared our vision of collaboration in the BCI space. At NeuraSeed BCI Expo 2024, Dr. Vikash Gilja will discuss his illustrious career and field perspective in BCI. - Neilank K. Jha, MD, FRCS(C), MSc, MBA, Conference Chair

Introducing our second speaker in the NeuraSeed BCI Expo 2024 Speaker Series: Dr. J Mocco, Chief Medical Officer of Synchron. Synchron is a pioneer medical device company, recognized as the first to receive FDA approval for an implantable Brain-Computer Interface (BCI) device. Their flagship product, the Stentrode, is implanted endovascularly to record neural activity along the brain's neural pathways in a minimally invasive manner. Synchron is at the forefront of neurotechnology, aiming to revolutionize the treatment of neurological conditions and enhance human capabilities. At NeuraSeed BCI Expo 2024, Dr. J Mocco will discuss Synchron's leading research efforts within the BCI field.

Introducing our NeuraSeed BCI Expo 2024 Speaker Series! Our first speaker in the series is Dr. Nicolas Vachicouras, Co-Founder and CEO of Neurosoft Bioelectronics. The vision of Neurosoft Bioelectronics is to improve the treatment of severe neurological disorders, such as epilepsy, tinnitus and deafness by developing interfaces for the brain. Their focus is on stretchable technology which includes techniques to engineer elasticity in thin metal films of sub-micron thickness, deposited on soft silicone substrates. This enables manufacturing of implants that can achieve long-term bio-integration in the body. Their soft electrode technology can reduce the risk of damaging neural structures, as the devices are softer and thinner than current clinical electrodes, which has the potential to enable new therapies.

The Musk Effect in BCI Elon Musk revolutionized the EV industry through a collaborative approach, understanding that a small piece of a big pie is better than a large piece of no pie. Through Musk’s leadership, Tesla allowed other automakers to utilize their technology in good faith without repercussions. Effectively, through this strategy Musk expanded the EV industry and cemented Tesla as a pioneer in the space. This contribution alone would warrant Musk’s compensation package as evidenced by the steep rise in Tesla’s market cap. Similarly, Neuralink through Musk has resulted in the capital markets generating interest in the Brain Computer Interface (BCI) space and these funds are advancing R&D around the globe. It is imperative as an industry that we work collaboratively to advance the field in the interest of the beneficiaries of this technology: the patients. It is important to eventually operate in a profitable manner to remain sustainable and Musk’s entry into this field has resulted in an influx of capital. These funds are enabling BCI companies to have the runway to achieve profitability in the near future through commercialization of products that improve the quality of life of patients. For example, this technology can help those with ALS, Stroke, Spinal Cord Injury & lethal Brain Cancer. Blackrock Neurotech’s recent $200MM infusion from Tether.io could also be tied back in large part to Musk’s entry into the BCI space. Just as Tiger, Jordan & Gretzky sparked interest in golf, basketball and hockey, similarly, Musk has generated awareness in BCI. Our conference NeuraSeed BCI Expo 2024 focuses on Clinical Progress & Capital Markets in the BCI space. NKJ